Francesco Bertoni

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 66

Top Venues

British journal of haematology

Nature

Blood

Molecular cancer therapeutics

Istituto Oncologico della Svizzera Italiana

Università degli Studi di Milano (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Oncologico della Svizzera Italiana Mar 01 2020

Switzerland

Medico Consulente di Ricerca :: Medical Oncology

Institute of Oncology Research Oct 01 2011

Switzerland

Institute deputy director and group leader :: Lymphoma Genomics

Istituto Oncologico della Svizzera Italiana Mar 01 2003 - Sep 30 2011

Switzerland

deputy director and group leader :: Laboratory of Experimental Oncology

Barts and The London School of Medicine and Dentistry Oct 01 1999 - Feb 28 2003

United Kingdom

visiting research fellow :: Department of Experimental Haematology

Istituto Oncologico della Svizzera Italiana Apr 01 1999 - Sep 30 1999

Switzerland

visiting research fellow :: Laboratory of Experimental Oncology

Istituto Di Ricerche Farmacologiche Mario Negri Apr 16 1998 - Mar 31 1999

Italy

research fellow and civil service :: Molecular Pharmacology Unit, Department of Oncology

University College London Institute of Child Health Jan 01 1998 - Apr 15 1998

United Kingdom

visiting research fellow :: Molecular Haematology Unit

Ospedale Regionale di Locarno Jan 01 1996 - Dec 31 1997

Switzerland

Specialty research fellow :: Medical Oncology Department and Bone Marrow Transplantation Laboratory, Servizio Oncologico Cantonale

Ospedale Maggiore Policlinico Feb 01 1995 - Dec 31 1995

Italy

Specialty School fellow :: Service of Medical Oncology

San Raffaele Hospital Nov 01 1991 - Jan 31 1995

Italy

attending student :: Division of Medicine II

Education History

Università degli Studi di Milano Sep 01 1988 - Jul 26 1994

Italy

PHD :: Faculty of Medicine

Publications

Francesca Zammarchi, Karin E Havenith, Nikoleta Sachini, Narinder Janghra, Simon Chivers, Esohe Idusogie, Eugenio Gaudio, Chiara Tarantelli, Francois Bertelli, Kathleen Santos, Peter Tyrer, Simon Corbett, Filippo Spriano, Gaetanina Golino, Luciano Cascione, Francesco Bertoni, John A Hartley, Patrick H van Berkel
ADCT-602, a novel PBD dimer-containing antibody-drug conjugate for treating CD22-positive hematological malignancies. Molecular cancer therapeutics (2024)
Francesca Zammarchi, Karin E Havenith, Nikoleta Sachini, Narinder Janghra, Simon Chivers, Esohe Idusogie, Eugenio Gaudio, Chiara Tarantelli, Francois Bertelli, Kathleen Santos, Peter Tyrer, Simon Corbett, Filippo Spriano, Gaetanina Golino, Luciano Cascione, Francesco Bertoni, John A Hartley, Patrick H van Berkel
ADCT-602, a Novel PBD Dimer-containing Antibody-Drug Conjugate for Treating CD22-positive Hematologic Malignancies. Molecular cancer therapeutics 23 (4) (2024)
Filippo Spriano, Chiara Tarantelli, Luciano Cascione, Eugenio Gaudio, Gaetanina Golino, Lorenzo Scalise, Maria Teresa Cacciapuoti, Emanuele Zucca, Anastasios Stathis, Patrick H Van Berkel, Giorgio Inghirami, Francesca Zammarchi, Francesco Bertoni
Targeting CD25+ lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents. British journal of haematology (2024)
Simon Garaudé, Romina Marone, Rosalba Lepore, Anna Devaux, Astrid Beerlage, Denis Seyres, Alessandro Dell' Aglio, Darius Juskevicius, Jessica Zuin, Thomas Burgold, Sisi Wang, Varun Katta, Garret Manquen, Yichao Li, Clément Larrue, Anna Camus, Izabela Durzynska, Lisa C Wellinger, Ian Kirby, Patrick H van Berkel, Christian Kunz, Jérôme Tamburini, Francesco Bertoni, Corinne C Widmer, Shengdar Q Tsai, Federico Simonetta, Stefanie Urlinger, Lukas T Jeker
Selective haematological cancer eradication with preserved haematopoiesis. Nature 630 (8017) (2024)
Simon Garaudé, Romina Marone, Rosalba Lepore, Anna Devaux, Astrid Beerlage, Denis Seyres, Alessandro Dell' Aglio, Darius Juskevicius, Jessica Zuin, Thomas Burgold, Sisi Wang, Varun Katta, Garret Manquen, Yichao Li, Clément Larrue, Anna Camus, Izabela Durzynska, Lisa C Wellinger, Ian Kirby, Patrick H van Berkel, Christian Kunz, Jérôme Tamburini, Francesco Bertoni, Corinne C Widmer, Shengdar Q Tsai, Federico Simonetta, Stefanie Urlinger, Lukas T Jeker
Selective haematological cancer eradication with preserved haematopoiesis. Nature (2024)
Simon Garaudé, Romina Marone, Rosalba Lepore, Anna Devaux, Astrid Beerlage, Denis Seyres, Alessandro Dell' Aglio, Darius Juskevicius, Jessica Zuin, Thomas Burgold, Sisi Wang, Varun Katta, Garret Manquen, Yichao Li, Clément Larrue, Anna Camus, Izabela Durzynska, Lisa C Wellinger, Ian Kirby, Patrick H van Berkel, Christian Kunz, Jérôme Tamburini, Francesco Bertoni, Corinne C Widmer, Shengdar Q Tsai, Federico Simonetta, Stefanie Urlinger, Lukas T Jeker
Selective haematological cancer eradication with preserved haematopoiesis. Nature (2024)
Francesca Zammarchi, Karin E Havenith, Nikoleta Sachini, Narinder Janghra, Simon Chivers, Esohe Idusogie, Eugenio Gaudio, Chiara Tarantelli, Francois Bertelli, Kathleen Santos, Peter Tyrer, Simon Corbett, Filippo Spriano, Gaetanina Golino, Luciano Cascione, Francesco Bertoni, John A Hartley, Patrick H van Berkel
ADCT-602, a Novel PBD Dimer-containing Antibody-Drug Conjugate for Treating CD22-positive Hematologic Malignancies. Molecular cancer therapeutics 23 (4) (2024)
Simon Garaudé, Romina Marone, Rosalba Lepore, Anna Devaux, Astrid Beerlage, Denis Seyres, Alessandro Dell' Aglio, Darius Juskevicius, Jessica Zuin, Thomas Burgold, Sisi Wang, Varun Katta, Garret Manquen, Yichao Li, Clément Larrue, Anna Camus, Izabela Durzynska, Lisa C Wellinger, Ian Kirby, Patrick H van Berkel, Christian Kunz, Jérôme Tamburini, Francesco Bertoni, Corinne C Widmer, Shengdar Q Tsai, Federico Simonetta, Stefanie Urlinger, Lukas T Jeker
Selective haematological cancer eradication with preserved haematopoiesis. Nature 630 (8017) (2024)
Simon Garaudé, Romina Marone, Rosalba Lepore, Anna Devaux, Astrid Beerlage, Denis Seyres, Alessandro Dell' Aglio, Darius Juskevicius, Jessica Zuin, Thomas Burgold, Sisi Wang, Varun Katta, Garret Manquen, Yichao Li, Clément Larrue, Anna Camus, Izabela Durzynska, Lisa C Wellinger, Ian Kirby, Patrick H van Berkel, Christian Kunz, Jérôme Tamburini, Francesco Bertoni, Corinne C Widmer, Shengdar Q Tsai, Federico Simonetta, Stefanie Urlinger, Lukas T Jeker
Selective haematological cancer eradication with preserved haematopoiesis. Nature 630 (8017) (2024)
Simon Garaudé, Romina Marone, Rosalba Lepore, Anna Devaux, Astrid Beerlage, Denis Seyres, Alessandro Dell' Aglio, Darius Juskevicius, Jessica Zuin, Thomas Burgold, Sisi Wang, Varun Katta, Garret Manquen, Yichao Li, Clément Larrue, Anna Camus, Izabela Durzynska, Lisa C Wellinger, Ian Kirby, Patrick H van Berkel, Christian Kunz, Jérôme Tamburini, Francesco Bertoni, Corinne C Widmer, Shengdar Q Tsai, Federico Simonetta, Stefanie Urlinger, Lukas T Jeker
Selective haematological cancer eradication with preserved haematopoiesis. Nature (2024)
Simon Garaudé, Romina Marone, Rosalba Lepore, Anna Devaux, Astrid Beerlage, Denis Seyres, Alessandro Dell' Aglio, Darius Juskevicius, Jessica Zuin, Thomas Burgold, Sisi Wang, Varun Katta, Garret Manquen, Yichao Li, Clément Larrue, Anna Camus, Izabela Durzynska, Lisa C Wellinger, Ian Kirby, Patrick H van Berkel, Christian Kunz, Jérôme Tamburini, Francesco Bertoni, Corinne C Widmer, Shengdar Q Tsai, Federico Simonetta, Stefanie Urlinger, Lukas T Jeker
Selective haematological cancer eradication with preserved haematopoiesis. Nature 630 (8017) (2024)
Simon Garaudé, Romina Marone, Rosalba Lepore, Anna Devaux, Astrid Beerlage, Denis Seyres, Alessandro Dell' Aglio, Darius Juskevicius, Jessica Zuin, Thomas Burgold, Sisi Wang, Varun Katta, Garret Manquen, Yichao Li, Clément Larrue, Anna Camus, Izabela Durzynska, Lisa C Wellinger, Ian Kirby, Patrick H van Berkel, Christian Kunz, Jérôme Tamburini, Francesco Bertoni, Corinne C Widmer, Shengdar Q Tsai, Federico Simonetta, Stefanie Urlinger, Lukas T Jeker
Selective haematological cancer eradication with preserved haematopoiesis. Nature 630 (8017) (2024)
Francesca Guidetti, Alberto J Arribas, Giulio Sartori, Filippo Spriano, Laura Barnabei, Chiara Tarantelli, Reinhard Von Roemeling, Elizabeth Martinez, Emanuele Zucca, Francesco Bertoni
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors. Journal of clinical medicine 12 (2) (2023)
Carmen De Ramón Ortiz, Sisi Wang, Anastasios Stathis, Francesco Bertoni, Thorsten Zenz, Urban Novak, Federico Simonetta
How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma? Hematological oncology (2023)
Francesca Guidetti, Alberto J Arribas, Giulio Sartori, Filippo Spriano, Laura Barnabei, Chiara Tarantelli, Reinhard Von Roemeling, Elizabeth Martinez, Emanuele Zucca, Francesco Bertoni
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors. Journal of clinical medicine 12 (2) (2023)
Francesca Guidetti, Alberto J Arribas, Giulio Sartori, Filippo Spriano, Laura Barnabei, Chiara Tarantelli, Reinhard Von Roemeling, Elizabeth Martinez, Emanuele Zucca, Francesco Bertoni
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors. Journal of clinical medicine 12 (2) (2023)
Elaine Y L Chung, Giulio Sartori, Maurilio Ponzoni, Luciano Cascione, Valdemar Priebe, Zijun Y Xu-Monette, Xiaosheng Fang, Mingzhi Zhang, Chiara Rusconi, Alexandar Tzankov, Andrea Rinaldi, Jacopo Sgrignani, Emanuele Zucca, Davide Rossi, Andrea Cavalli, Giorgio Inghirami, David W Scott, Ken H Young, Francesco Bertoni
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells. British journal of haematology (2023)
Francesca Guidetti, Alberto J Arribas, Giulio Sartori, Filippo Spriano, Laura Barnabei, Chiara Tarantelli, Reinhard Von Roemeling, Elizabeth Martinez, Emanuele Zucca, Francesco Bertoni
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors. Journal of clinical medicine 12 (2) (2023)
Giulio Sartori, Chiara Tarantelli, Filippo Spriano, Eugenio Gaudio, Luciano Cascione, Michele Mascia, Marilia Barreca, Alberto J Arribas, Luca Licenziato, Gaetanina Golino, Adele Ferragamo, Stefano Pileri, Giovanna Damia, Emanuele Zucca, Anastasios Stathis, Oliver Politz, Antje M Wengner, Francesco Bertoni
The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib. British journal of haematology (2023)
Alberto J Arribas, Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas, Eugenio Gaudio, Chiara Tarantelli, Afua Adjeiwaa Mensah, Filippo Spriano, Antonella Zucchetto, Francesca Maria Rossi, Andrea Rinaldi, Manuel Castro de Moura, Sandra Jovic, Roberta Bordone Pittau, Anastasios Stathis, Georg Stussi, Valter Gattei, Jennifer R Brown, Manel Esteller, Emanuele Zucca, Davide Rossi, Francesco Bertoni
ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms. Molecular cancer therapeutics (2023)
Alberto J Arribas, Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas, Eugenio Gaudio, Chiara Tarantelli, Afua Adjeiwaa Mensah, Filippo Spriano, Antonella Zucchetto, Francesca Maria Rossi, Andrea Rinaldi, Manuel Castro de Moura, Sandra Jovic, Roberta Bordone Pittau, Anastasios Stathis, Georg Stussi, Valter Gattei, Jennifer R Brown, Manel Esteller, Emanuele Zucca, Davide Rossi, Francesco Bertoni
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms. bioRxiv : the preprint server for biology (2023)
Zoe Johnson, Chiara Tarantelli, Elisa Civanelli, Luciano Cascione, Filippo Spriano, Amy Fraser, Pritom Shah, Tyzoon Nomanbhoy, Sara Napoli, Andrea Rinaldi, Karolina Niewola-Staszkowska, Michael Lahn, Dominique Perrin, Mathias Wenes, Denis Migliorini, Francesco Bertoni, Lars van der Veen, Giusy Di Conza
IOA-244 is a Non-ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance. Cancer research communications 3 (4) (2023)
Alberto J Arribas, Eugenio Gaudio, Sara Napoli, Charles Jean Yvon Herbaux, Chiara Tarantelli, Roberta Pittau Bordone, Luciano Cascione, Nicolas Munz, Luca Aresu, Jacopo Sgrignani, Andrea Rinaldi, Ivo Kwee, Davide Rossi, Andrea Cavalli, Emanuele Zucca, Georg Stussi, Anastasios Stathis, Callum Sloss, Matthew S Davids, Francesco Bertoni
PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansine. bioRxiv : the preprint server for biology (2023)
Yanping Yin, Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Ishwarya Murali, Stacey M Fernandes, Alberto J Arribas, Abdul K Hilli, Kjetil Taskén, Francesco Bertoni, Anthony R Mato, Emmanuel Normant, Jennifer R Brown, Geir Erland Tjønnfjord, Tero Aittokallio, Sigrid S Skånland
Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Domenico Maisano, Selena Mimmi, Vincenzo Dattilo, Fabiola Marino, Massimo Gentile, Eleonora Vecchio, Giuseppe Fiume, Nancy Nisticò, Annamaria Aloisio, Maria Penelope de Santo, Giovanni Desiderio, Vincenzo Musolino, Saverio Nucera, Francesca Sbrana, Sebastiano Andò, Simone Ferrero, Andrea Morandi, Francesco Bertoni, Ileana Quinto, Enrico Iaccino
A novel phage display based platform for exosome diversity characterization. Nanoscale 14 (8) (2022)
Lodovico Terzi di Bergamo, Francesca Guidetti, Davide Rossi, Francesco Bertoni, Luciano Cascione
HTGQC and shinyHTGQC: an R package and shinyR application for quality controls of HTG EDGE-seq protocols. GigaByte (Hong Kong, China) 2022 (2022)
Anastasios Stathis, Ulrich Mey, Sämi Schär, Felicitas Hitz, Christiane Pott, Nicolas Mach, Fatime Krasniqi, Urban Novak, Christian Schmidt, Karin Hohloch, Dirk Lars Kienle, Dagmar Hess, Alden A Moccia, Michael Unterhalt, Katrin Eckhardt, Stefanie Hayoz, Gabriela Forestieri, Davide Rossi, Stefan Dirnhofer, Luca Ceriani, Giulio Sartori, Francesco Bertoni, Christian Buske, Emanuele Zucca, Wolfgang Hiddemann
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma. Blood advances 6 (13) (2022)
Marilia Barreca, Noemie Lang, Chiara Tarantelli, Filippo Spriano, Paola Barraja, Francesco Bertoni
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences. Exploration of targeted anti-tumor therapy 3 (6) (2022)
Sara Napoli, Nicolas Munz, Francesca Guidetti, Francesco Bertoni
Enhancer RNAs (eRNAs) in Cancer: The Jacks of All Trades. Cancers 14 (8) (2022)
Filippo Spriano, Chiara Tarantelli, Alberto J Arribas, Eugenio Gaudio, Luciano Cascione, Luca Aresu, Andrea Rinaldi, Emanuele Zucca, Davide Rossi, Anastasios Stathis, Maximilien Murone, Freddy Radtke, Rajwinder Lehal, Francesco Bertoni
In vitro anti-lymphoma activity of the first-in-class pan-NOTCH transcription inhibitor CB-103. British journal of haematology (2022)
Marilia Barreca, Noemie Lang, Chiara Tarantelli, Filippo Spriano, Paola Barraja, Francesco Bertoni
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences. Exploration of targeted anti-tumor therapy 3 (6) (2022)
Tommaso Virgilio, Joy Bordini, Luciano Cascione, Giulio Sartori, Irene Latino, Daniel Molina Romero, Cristina Leoni, Murodzhon Akhmedov, Andrea Rinaldi, Alberto J Arribas, Diego Morone, Seyed Morteza Seyed Jafari, Marina Bersudsky, Aner Ottolenghi, Ivo Kwee, Anna Maria Chiaravalli, Fausto Sessa, Robert E Hunger, Antonino Bruno, Lorenzo Mortara, Elena Voronov, Silvia Monticelli, Ron N Apte, Francesco Bertoni, Santiago Fernandez Gonzalez
Subcapsular Sinus Macrophages Promote Melanoma Metastasis to the Sentinel Lymph Nodes via an IL1α-STAT3 Axis. Cancer immunology research 10 (12) (2022)
Lodovico Terzi di Bergamo, Francesca Guidetti, Davide Rossi, Francesco Bertoni, Luciano Cascione
HTGQC and shinyHTGQC: an R package and shinyR application for quality controls of HTG EDGE-seq protocols. GigaByte (Hong Kong, China) 2022 (2022)
Diana Giannuzzi, Laura Marconato, Antonella Fanelli, Luca Licenziato, Raffaella De Maria, Andrea Rinaldi, Luca Rotta, Nicole Rouquet, Giovanni Birolo, Piero Fariselli, Afua A Mensah, Francesco Bertoni, Luca Aresu
The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications. Lab animal 51 (7) (2022)
Chiara Tarantelli, Eleonora Cannas, Hillarie Ekeh, Carmelo Moscatello, Eugenio Gaudio, Luciano Cascione, Sara Napoli, Cesare Rech, Andrea Testa, Chiara Maniaci, Andrea Rinaldi, Emanuele Zucca, Anastasios Stathis, Alessio Ciulli, Francesco Bertoni
The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type. Exploration of targeted anti-tumor therapy 2 (6) (2021)
Marco De Martino, Davide De Biase, Floriana Forzati, Sara Carmela Credendino, Giuseppe Palma, Antonio Barbieri, Claudio Arra, Orlando Paciello, Eugenio Gaudio, Maurilio Ponzoni, Gabriella De Vita, Paolo Chieffi, Francesco Bertoni, Alfredo Fusco, Francesco Esposito
Publisher Correction: HMGA1-pseudogene7 transgenic mice develop B cell lymphomas. Scientific reports 11 (1) (2021)
Afua Adjeiwaa Mensah, Filippo Spriano, Giulio Sartori, Valdemar Priebe, Luciano Cascione, Eugenio Gaudio, Chiara Tarantelli, Elisa Civanelli, Luca Aresu, Andrea Rinaldi, Giovanna Damia, Emanuela Lovati, Emanuele Zucca, Anastasios Stathis, Claudio Pietra, Francesco Bertoni
Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors. Blood advances 5 (10) (2021)
Nicolas Munz, Luciano Cascione, Luca Parmigiani, Chiara Tarantelli, Andrea Rinaldi, Natasa Cmiljanovic, Vladimir Cmiljanovic, Rosalba Giugno, Francesco Bertoni, Sara Napoli
Exon-Intron Differential Analysis Reveals the Role of Competing Endogenous RNAs in Post-Transcriptional Regulation of Translation. Non-coding RNA 7 (2) (2021)
Giulio Sartori, Sara Napoli, Luciano Cascione, Elaine Yee Lin Chung, Valdemar Priebe, Alberto Jesus Arribas, Afua Adjeiwaa Mensah, Michela Dall'Angelo, Chiara Falzarano, Laura Barnabei, Mattia Forcato, Andrea Rinaldi, Silvio Bicciato, Margot Thome, Francesco Bertoni
ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Marco De Martino, Davide De Biase, Floriana Forzati, Sara Carmela Credendino, Giuseppe Palma, Antonio Barbieri, Claudio Arra, Orlando Paciello, Eugenio Gaudio, Maurilio Ponzoni, Gabriella De Vita, Paolo Chieffi, Francesco Bertoni, Alfredo Fusco, Francesco Esposito
HMGA1-pseudogene7 transgenic mice develop B cell lymphomas. Scientific reports 10 (1) (2020)
Valdemar Priebe, Giulio Sartori, Sara Napoli, Elaine Yee Lin Chung, Luciano Cascione, Ivo Kwee, Alberto Jesus Arribas, Afua Adjeiwaa Mensah, Andrea Rinaldi, Maurilio Ponzoni, Emanuele Zucca, Davide Rossi, Dimitar G Efremov, Georg Lenz, Margot Thome, Francesco Bertoni
Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type. Cancers 12 (7) (2020)
Marilia Barreca, Virginia Spanò, Alessandra Montalbano, Mercedes Cueto, Alfredo Moreno, Irem Deniz, Ayşegül Erdoğan, Lada Lukić Bilela, Corentin Moulin, Elisabeth Taffin-de-Givenchy, Filippo Spriano, Giuseppe Perale, Mohamed Mehiri, Ana Rotter, Olivier P Thomas, Paola Barraja, Susana P Gaudêncio, Francesco Bertoni
Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes. Marine drugs 18 (12) (2020)
Andrea Unzue, Claudia Jessen-Trefzer, Dimitrios Spiliotopoulos, Eugenio Gaudio, Chiara Tarantelli, Jing Dong, Hongtao Zhao, Johanna Pachmayr, Stefan Zahler, Elena Bernasconi, Giulio Sartori, Luciano Cascione, Francesco Bertoni, Paweł Śledź, Amedeo Caflisch, Cristina Nevado
Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors. RSC medicinal chemistry 11 (6) (2020)
Diana Giannuzzi, Luca Giudice, Laura Marconato, Serena Ferraresso, Rosalba Giugno, Francesco Bertoni, Luca Aresu
Integrated analysis of transcriptome, methylome and copy number aberrations data of marginal zone lymphoma and follicular lymphoma in dog. Veterinary and comparative oncology 18 (4) (2020)
Alberto J Arribas, Andrea Rinaldi, Giorgia Chiodin, Ivo Kwee, Afua Adjeiwaa Mensah, Luciano Cascione, Davide Rossi, Meena Kanduri, Richard Rosenquist, Emanuele Zucca, Peter W Johnson, Gianluca Gaidano, Christopher C Oakes, Francesco Bertoni, Francesco Forconi
Genome-wide promoter methylation of hairy cell leukemia. Blood advances 3 (3) (2020)
Patrizia Mondello, Salvatore Cuzzocrea, Carmela Arrigo, Vincenzo Pitini, Michael Mian, Francesco Bertoni
STAT6 activation correlates with cerebrospinal fluid IL-4 and IL-10 and poor prognosis in primary central nervous system lymphoma. Hematological oncology 38 (1) (2019)
Chiara Tarantelli, Eugenio Gaudio, Petra Hillmann, Filippo Spriano, Giulio Sartori, Luca Aresu, Luciano Cascione, Denise Rageot, Ivo Kwee, Florent Beaufils, Emanuele Zucca, Anastasios Stathis, Matthias P Wymann, Vladimir Cmiljanovic, Doriano Fabbro, Francesco Bertoni
The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax. Cancers 11 (6) (2019)
Tayla B Heavican, Alyssa Bouska, Jiayu Yu, Waseem Lone, Catalina Amador, Qiang Gong, Weiwei Zhang, Yuping Li, Bhavana J Dave, Maarja-Liisa Nairismägi, Timothy C Greiner, Julie Vose, Dennis D Weisenburger, Cynthia Lachel, Chao Wang, Kai Fu, Jadd M Stevens, Soon Thye Lim, Choon Kiat Ong, Randy D Gascoyne, Edoardo Missiaglia, Francois Lemonnier, Corinne Haioun, Sylvia Hartmann, Martin Bjerregård Pedersen, Maria Antonella Laginestra, Ryan A Wilcox, Bin Tean Teh, Noriaki Yoshida, Koichi Ohshima, Masao Seto, Andreas Rosenwald, German Ott, Elias Campo, Lisa M Rimsza, Elaine S Jaffe, Rita M Braziel, Francesco d'Amore, Giorgio Inghirami, Francesco Bertoni, Laurence de Leval, Philippe Gaulard, Louis M Staudt, Timothy W McKeithan, Stefano Pileri, Wing C Chan, Javeed Iqbal
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood 133 (15) (2019)
Valentina Restelli, Monica Lupi, Rosaria Chilà, Micaela Vagni, Chiara Tarantelli, Filippo Spriano, Eugenio Gaudio, Francesco Bertoni, Giovanna Damia, Laura Carrassa
DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas. Molecular cancer therapeutics 18 (7) (2019)
Binu K Sasi, Claudio Martines, Elena Xerxa, Fabiola Porro, Hilal Kalkan, Rosa Fazio, Sven Turkalj, Engin Bojnik, Beata Pyrzynska, Joanna Stachura, Abdessamad Zerrouqi, Małgorzata Bobrowicz, Magdalena Winiarska, Valdemar Priebe, Francesco Bertoni, Larry Mansouri, Richard Rosenquist, Dimitar G Efremov
Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma. Leukemia 33 (10) (2019)
Maria Antonella Laginestra, Luciano Cascione, Giovanna Motta, Fabio Fuligni, Claudio Agostinelli, Maura Rossi, Maria Rosaria Sapienza, Simona Righi, Alessandro Broccoli, Valentina Indio, Federica Melle, Valentina Tabanelli, Angelica Calleri, Domenico Novero, Fabio Facchetti, Giorgio Inghirami, Elena Sabattini, Francesco Bertoni, Stefano A Pileri
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 33 (2) (2019)
Filippo Spriano, Chiara Tarantelli, Eugenio Gaudio, Magdalena M Gerlach, Valdemar Priebe, Luciano Cascione, Elena Bernasconi, Altea Targa, Michele Mascia, Stefan Dirnhofer, Anastasios Stathis, Emanuele Zucca, Francesco Bertoni
Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP-319 in pre-clinical models of aggressive lymphomas. British journal of haematology 187 (5) (2019)
Luciano Cascione, Luca Giudice, Serena Ferraresso, Laura Marconato, Diana Giannuzzi, Sara Napoli, Francesco Bertoni, Rosalba Giugno, Luca Aresu
Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization. Non-coding RNA 5 (3) (2019)
Filippo Spriano, Elaine Y Chung, Nicolo' Panini, Luciano Cascione, Andrea Rinaldi, Eugenio Erba, Anastasios Stathis, Maurizio D'Incalci, Francesco Bertoni, Raffaella Gatta
Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma. British journal of haematology 184 (6) (2018)
Annarita Conconi, Emanuele Zucca, Gloria Margiotta-Casaluci, Katharine Darling, Barbara Hasse, Manuel Battegay, Cornelia Staehelin, Urban Novak, Patrick Schmid, Alexandra Scherrer, Stephan Dirnhofer, Ivo Kwee, Luca Nassi, Franco Cavalli, Gianluca Gaidano, Francesco Bertoni, Enos Bernasconi, null null
Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals. Hematological oncology 36 (5) (2018)
Chiara Tarantelli, Eugenio Gaudio, Luciano Cascione, Anastasios Stathis, Emanuele Zucca, Francesco Bertoni
In vitro demonstration of synergism with pixantrone combined with targeted agents in lymphomas. British journal of haematology 186 (1) (2018)
Francesco Bertoni
Let's give BACH2 a breath of fresh air. Blood 130 (6) (2018)
Silvia Da Ros, Luca Aresu, Serena Ferraresso, Eleonora Zorzan, Eugenio Gaudio, Francesco Bertoni, Mauro Dacasto, Mery Giantin
Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach. PloS one 13 (12) (2018)
Elisa Bergaggio, Chiara Riganti, Giulia Garaffo, Nicoletta Vitale, Elisabetta Mereu, Cecilia Bandini, Elisa Pellegrino, Verdiana Pullano, Paola Omedè, Katia Todoerti, Luciano Cascione, Valentina Audrito, Anna Riccio, Antonio Rossi, Francesco Bertoni, Silvia Deaglio, Antonio Palumbo, Roberto Piva
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies. Blood 133 (2) (2018)
Francesco Bertoni, Anastasios Stathis
Staining the target: CD37 expression in lymphomas. Blood 128 (26) (2018)
Murodzhon Akhmedov, Amanda J Kedaigle, Renan Escalante Chong, Roberto Montemanni, Francesco Bertoni, Ernest Fraenkel, Ivo Kwee
PCSF: An R-package for network-based interpretation of high-throughput data. PLoS computational biology 13 (7) (2017)
Bojan Bujisic, Aude De Gassart, Rémy Tallant, Olivier Demaria, Léa Zaffalon, Sonia T Chelbi, Michel Gilliet, Francesco Bertoni, Fabio Martinon
Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth. Blood 129 (17) (2017)
Eugenio Gaudio, Francesco Paduano, Sandra Pinton, Sabrina D'Agostino, Roberta Rocca, Giosuè Costa, Apollinaire Ngankeu, Rami I Aqeilan, Carlo M Croce, Francesco Bertoni, Stefano Alcaro, Francesco Trapasso
TCL1A interacts with TP63 and enhances the survival of Raji Burkitt lymphoma cell line. British journal of haematology 183 (3) (2017)
Elena Bernasconi, Eugenio Gaudio, Pascale Lejeune, Chiara Tarantelli, Luciano Cascione, Ivo Kwee, Filippo Spriano, Andrea Rinaldi, Afua A Mensah, Elaine Chung, Anastasios Stathis, Stephan Siegel, Norbert Schmees, Matthias Ocker, Emanuele Zucca, Bernard Haendler, Francesco Bertoni
Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma. British journal of haematology 178 (6) (2017)
Luciano Cascione, Andrea Rinaldi, Annalisa Chiappella, Ivo Kwee, Giovannino Ciccone, Michael Altenbuchinger, Christian Kohler, Umberto Vitolo, Giorgio Inghirami, Francesco Bertoni
Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1-2 study. British journal of haematology 182 (3) (2017)
Emanuele Zucca, Francesco Bertoni
The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance. Blood 127 (17) (2016)
Irene Scarfo, Elisa Pellegrino, Elisabetta Mereu, Ivo Kwee, Luca Agnelli, Elisa Bergaggio, Giulia Garaffo, Nicoletta Vitale, Manuel Caputo, Rodolfo Machiorlatti, Paola Circosta, Francesco Abate, Antonella Barreca, Domenico Novero, Susan Mathew, Andrea Rinaldi, Enrico Tiacci, Sara Serra, Silvia Deaglio, Antonino Neri, Brunangelo Falini, Raul Rabadan, Francesco Bertoni, Giorgio Inghirami, Roberto Piva, null null
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts. Blood 127 (2) (2015)
Alberto J Arribas, Andrea Rinaldi, Afua A Mensah, Ivo Kwee, Luciano Cascione, Eloy F Robles, Jose A Martinez-Climent, David Oscier, Luca Arcaini, Luca Baldini, Roberto Marasca, Catherine Thieblemont, Josette Briere, Francesco Forconi, Alberto Zamò, Massimiliano Bonifacio, Manuela Mollejo, Fabio Facchetti, Stephan Dirnhofer, Maurilio Ponzoni, Govind Bhagat, Miguel A Piris, Gianluca Gaidano, Emanuele Zucca, Davide Rossi, Francesco Bertoni
DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features. Blood 125 (12) (2015)

Francesco Bertoni.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Francesco Bertoni